SMTL ID : 7r75.1

Structure of human SHP2 in complex with compound 16

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.83 Å

Oligo State

monomer

Ligands

1 x 33I: 6-(4-amino-4-methylpiperidin-1-yl)-3-(3-chlorophenyl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one(Non-covalent)

33I.1: 15 residues within 4Å: Chain A: T.114, E.116, R.117, F.119, H.120, N.223, T.224, T.225, E.255, E.256, T.259, L.260, P.497, K.498, Q.501 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:T.225, A:E.255, A:T.259, A:L.260, A:P.497, A:Q.501 Hydrogen bonds: A:R.117, A:E.255, A:E.256, A:T.259 pi-Cation interactions: A:R.117

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Czako, B. et al., Discovery of 6-[(3 S ,4 S )-4-Amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-3-(2,3-dichlorophenyl)-2-methyl-3,4-dihydropyrimidin-4-one (IACS-15414), a Potent and Orally Bioavailable SHP2 Inhibitor. J.Med.Chem. (2021)

Release Date

2021-10-27

Peptides

Tyrosine-protein phosphatase non-receptor type 11: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein phosphatase non-receptor type 11

Related Entries With Identical Sequence